Get startedLog in
    Picture of Seelos Therapeutics logo

    SEELQ — Seelos Therapeutics News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro Cap
    All News

    Brief: IX Biopharma Says Entered Exclusive License Agreement With Seelos Therapeutics

    Picture of Seelos Therapeutics logoSeelos Therapeutics
    24/11/2021 06:08
    Nov 24 (Reuters) - IX Biopharma Ltd  IXBI.SI :
    * ENTERED INTO AN EXCLUSIVE LICENSE AGREEMENT WITH SEELOS
THERAPEUTICS
    * WILL RECEIVE US$9 MILLION UPFRONT PAYMENT TO BE SATISFIED
IN
CASH AND SHARES
    * ALSO ELIGIBLE FOR UP TO US$239 MILLION IN MILESTONE
PAYMENTS AS
PART OF DEAL

Source text for Eikon:  ID:nSN4DNx5y 
Further company coverage:  IXBI.SI 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Seelos Therapeutics

    See all news